Z C Li

ORCID: 0009-0005-0773-3316
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV, Drug Use, Sexual Risk
  • HIV, TB, and STIs Epidemiology
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • Sex work and related issues
  • CAR-T cell therapy research
  • Virus-based gene therapy research

Beijing YouAn Hospital
2018-2024

Capital Medical University
2018-2024

University of Alabama at Birmingham
2012

To optimise patients' outcomes and gain insight into transmitted drug resistance (TDR) among human immunodeficiency virus (HIV)-1 treatment-naive patients in Beijing, the prevalence of TDR was assessed. Demographic clinical data 1241 diagnosed between April 2014 February 2015 were collected. defined using Stanford University HIV mutations database. The risk factors evaluated by multi-logistic regression analysis. Among 932 successfully amplified cases, most male (96.78%) infected through men...

10.1017/s0950268817003016 article EN Epidemiology and Infection 2018-01-18

Abstract Background There is limited literature available regarding the knowledge and use of HIV pre-exposure prophylaxis (PrEP) among men who have sex with (MSM) sexually transmitted infections (STIs). Objective This study’s objective was to explore PrEP cascade stages (knowledge, willingness use, use) MSM STIs in China, order promote implementation this population. Methods A cross-sectional study conducted using a respondent-driven sampling method 19 cities from January August 2022. The...

10.2196/65713 article EN cc-by JMIR Public Health and Surveillance 2024-12-30

Objective: To understand the knowledge awareness and service acceptance of HIV non-occupational post-exposure prophylaxis (nPEP) men who have sex with (MSM) among college students in three cities China. Methods: Male 10 universities Beijing, Shenzhen Kunming aged 18 above had last 3 months were recruited as research objects by cluster stratified sampling from March 15, 2019 to April 14, 2019.Basic information, sexual behavior characteristics, knowledge, nPEP collected through online...

10.3760/cma.j.cn112150-20200310-00302 article EN PubMed 2020-11-06

Objectives To investigate the seroreversion time in HIV‐1‐exposed but uninfected infants from two tertiary hospitals China. Methods This study retrospectively investigated data of perinatal, Beijing and Shenzhen. Maternal infant medical records both January 2009 to December 2019 were reviewed, HIV antibody times determined. From 2019, a total 485 enrolled. The majority born at term with normal birth weight. Results rates 89.3%, 94.2% 100% 12, 18 24 months age, respectively. There no...

10.1111/hiv.13026 article EN HIV Medicine 2020-12-01

Background Adenoviral (Ad) vectors have been used for a variety of vaccine applications. Traditionally, Ad-based vaccines are designed to express antigens through transgene expression. However, in some cases these conventional had sub-optimal clinical results. These results attributed part preexisting Ad serotype 5(Ad5) immunity. To circumvent the need antigen expression, “antigen capsid-incorporation” strategy has developed and development. In addition, increase magnitude and/or breadth...

10.1186/1742-4690-9-s2-p22 article EN cc-by Retrovirology 2012-09-01

Objective: To evaluate the effects of cognitive and behavioral intervention on self-management, self-efficacy quality life HIV infection cases. Methods: A total 200 cases visiting STD/AIDS clinic at Beijing Youan Hospital from January to December 2018 were recruited in this study. They divided into group control based method random number table. Both groups received routine outpatient care. The addition self-management scale, scale used before after for 3 months respectively group,...

10.3760/cma.j.cn112338-20220119-00056 article EN PubMed 2022-07-10
Coming Soon ...